Loomis, Sayles & Company’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-391
Closed -$15K 931
2023
Q4
$15K Buy
391
+107
+38% +$3.27K ﹤0.01% 725
2023
Q3
$8K Buy
284
+179
+170% +$5.6K ﹤0.01% 850
2023
Q2
$3K Buy
+105
New +$3.07K ﹤0.01% 931
2021
Q1
Sell
-470
Closed -$15K 886
2020
Q4
$15K Buy
+470
New +$13.6K ﹤0.01% 654

Other funds holding SNV

Loomis, Sayles & Company's SNV Position: Q1 2024 in Review

Loomis, Sayles & Company sold out of Synovus (SNV) in Q1 2024, closing a stake of 391 shares — an estimated $15K sold.

Loomis, Sayles & Company first reported a position in SNV in Q4 2020 and held it in 4 quarters. The position peaked at $15K in Q4 2023. 408 funds tracked by Wall St. Rank hold SNV as of Q1 2024.

  • Loomis, Sayles & Company reported no remaining Synovus position as of Q1 2024 after selling out during the quarter.
  • Loomis, Sayles & Company sold 391 Synovus shares in Q1 2024, an estimated $15K.
  • Loomis, Sayles & Company first reported a position in Synovus in Q4 2020 and held it in 4 quarters.
  • Loomis, Sayles & Company's Synovus position peaked at $15K in Q4 2023.
  • 408 funds tracked by Wall St. Rank held Synovus as of Q1 2024.

Based on Loomis, Sayles & Company's 13F filing for Q1 2024, filed 14 May 2024.